FindTrial
Sign In

A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia

A randomized controlled trial of venlafaxine versus placebo for depression amongst persons with lymphoma or leukaemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN51232664
Enrollment
Unknown
Registered
2003-09-12
Start date
2001-01-07
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression amongst persons with lymphoma or leukaemia Mental and Behavioural Disorders Reaction to severe stress, and adjustment disorders

Interventions

A randomized controlled trial of venlafaxine versus placebo

Sponsors

Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Persons with lymphoma or leukaemia with depression as assessed using the Hamilton Rating Scale for Depression.

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Primary

MeasureTime frame
Hamilton Rating Scale for Depression—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026